EDITAS MEDICINE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- EDITAS MEDICINE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-09-30 was 78.80K shares, a 40.68% decline year-over-year.
- EDITAS MEDICINE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-06-30 was 277.26K shares, a 43.67% increase year-over-year.
- EDITAS MEDICINE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2019-03-31 was 146.17K shares, a 52.62% decline year-over-year.
- EDITAS MEDICINE, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2018-09-30 was 132.86K shares, a 848.16% increase year-over-year.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2019-09-30 | 78.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | |
| 2019-06-30 | 277.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | |
| 2019-03-31 | 146.17K shares 10-Q · filed 2019-05-08 | |
| 2018-09-30 | 132.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | |
| 2018-06-30 | 192.98K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | |
| 2018-03-31 | 308.50K shares 10-Q · filed 2018-05-04 | |
| 2017-09-30 | 14.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | |
| 2017-06-30 | 14.93K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | |
| 2017-03-31 | 85.87K shares 10-Q · filed 2017-05-15 | |
| 2016-09-30 | 41.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2016-06-30 | 10.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | |
| 2016-03-31 | 8.67K shares 10-Q · filed 2016-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |